Daniel Wojenski Profile
Daniel Wojenski

@DWRx

Followers
59
Following
53
Media
1
Statuses
11

Hematology/Oncology Pharmacy Practice Coordinator @northwesternmed / Oncology PGY2 RPD

Chicago, IL
Joined September 2010
Don't wanna be here? Send us removal request.
@TalhaKhanRx
Talha K, PharmD, BCOP
2 years
Northwestern Pride! 💜🏳️‍🌈 @DWRx @BlaneyBrendan @jerbunnyman
0
3
26
@TalhaKhanRx
Talha K, PharmD, BCOP
3 years
Had a great time seeing past & current @NorthwesternMed colleagues @bpromd @reemkarmali @DWRx at Ultmann Chicago Lymphoma Conference @LurieCancer
0
4
26
@DWRx
Daniel Wojenski
5 years
Wonderful presentation on the Updates from ASH 2020 from @cyn_hrx at TCT this year! If you didn’t catch it, make sure to go back and watch! I was lucky enough to collaborate with her and present the second half! #TCTM21 #oncopharm @LurieCancer @NorthwesternMed
0
0
7
@DWRx
Daniel Wojenski
5 years
So proud of @Jiller12 and her research presentation at ASH! :)
@LurieCancer
Lurie Cancer Center
5 years
#ASH20 If you missed seeing Jenn Miller present findings from this cohort study evaluating therapies for treating relapsed and refractory #AML conducted at @LurieCancer @NorthwesternMed, you can view the paper here 👉 https://t.co/MNwMVUaRB6
0
0
7
@BloodPortfolio
Blood Journals Portfolio
6 years
Editorial: Introduction to a How I Treat series on major complications after allogeneic stem cell transplantation
0
16
40
@NEJM
NEJM
6 years
Asciminib was active in heavily pretreated patients with CML who had resistance to or unacceptable side effects from TKIs, including patients in whom ponatinib had failed and those with a T315I mutation.
0
58
121